AU Patent

AU2023270354A1 — Bowel-cleansing composition

Assigned to Daewoong Therapeutics Inc · Expires 2025-06-12 · 1y expired

What this patent protects

The present invention provides a bowel-cleansing composition comprising anhydrous magnesium sulfate, potassium sulfate, and anhydrous sodium sulfate, in 5 combination with prucalopride or sodium picosulfate. 12

USPTO Abstract

The present invention provides a bowel-cleansing composition comprising anhydrous magnesium sulfate, potassium sulfate, and anhydrous sodium sulfate, in 5 combination with prucalopride or sodium picosulfate. 12

Drugs covered by this patent

Magnesium Sulfate (Magnesium Sulfate) · Pfizer

Patent Metadata

Patent number: AU2023270354A1
Jurisdiction: AU
Classification: —
Expires: 2025-06-12
Drug substance claim: No
Drug product claim: No
Assignee: Daewoong Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.